Catalyst Wire Dossier Catalyst Wire Dossier

XYOSTED

Testosterone enanthate · Antares Pharma, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for XYOSTED, covering 2018-03-30 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism [Phase 3]

See pricing